Funding opportunities

Below is a list of funding opportunities that may be of interest to the Ontario cancer research community.

If you wish to list a funding opportunity here, contact

Current funding opportunities

OICR Clinical Translation Pathway – Request for Applications

To accelerate translational cancer research so that precise, impactful and cost-effective treatments can benefit cancer patients, OICR has implemented a new Clinical Translation Pathway (CTP). The CTP will support practice-changing research in biomarkers, diagnostics and therapeutics that will advance early detection and intervention research and have a clear path to the clinic and clinical impact. It will focus on primary-diagnosed or early recurrent cancers. The pathway will be fueled by innovations emerging from OICR-supported research and from research originating from across the province of Ontario.

The CTP consists of separate funding streams that support preclinical, clinical, and convergent research. OICR is currently inviting applications for the following two funding streams:

Pre-Clinical Acceleration Team Awards (Pre-CATA): Supports pre-clinical projects with a clear path to the clinic, with a focus on pre-clinical development of biomarkers, diagnostics and therapeutics.

Funding available: $250,000 per year for up to three years. OICR anticipates supporting up to eight Pre-CATA projects.

Clinical Acceleration Team Awards (CATA): Supports early phase (I-II), prospective, biomarker-rich trials for clinical validation of biomarkers, diagnostics and therapeutics.

Funding available: $500,000 per year for up to three years. OICR anticipates supporting up to eight CATA trials.


Update: OICR acknowledges the current situation unfolding within Ontario hospitals and that many of our clinical colleagues are feeling additional pressures due to the dynamic in-hospital challenges presented by the ongoing pandemic. As such, OICR has decided to adjust the Letter of Intent deadline to May 17, 2021 by 5 p.m. EDT. The full application deadline remains unchanged. Additional details about the funding streams and how to apply can be found below.

Notice of Intent submission: No later than May 17, 2021
Letter of Intent deadline: May 17, 2021 by 5 p.m. EDT
Full application deadline: August 12, 2021 by 5 p.m. EDT
Notification of results: End of September 2021
Funding start date: October 1, 2021

How to apply: Pre-CATA RFA [PDF]CATA RFA [PDF]

Info session
Please find a link to the presentation from the April 16 info session.

Download the info session presentation [PDF] | Info session recording

If you’d like to discuss any preliminary ideas with the Clinical Translation team, please contact Dr. Teresa Petrocelli, Director, Clinical Translation at For questions about the submission and review process, please refer to the FAQ page before contacting the OICR Scientific Secretariat office at

Past funding opportunities

OMPRN Funding – Cancer Pathology Translational Research Grants

Ontario Molecular Pathology Research Network’s (OMPRN) vision is to create a province-wide network of pathologists collaborating to carry out high-quality cancer research with a clear potential for clinical utility. The OMPRN Steering Committee has developed objectives under the three broad themes of (i) Awareness & Outreach, (ii) Education, and (iii) Pathology-led Research. The Cancer Pathology Translational Research Grant (CPTRG) Streams address the latter objective by supporting projects in which the primary drivers are pathologists and the primary focus is on pathology cancer research.

Cancer Pathology Translational Research Grants will build the capacity of Ontario pathologists to undertake transdisciplinary research projects that advance the field of cancer diagnostic, prognostic or predictive testing and provide learning opportunities for pathology residents or early-career pathologists. See more details

Biostatistics Training Initiative – Junior Biostatistician Award

In an effort to continue to enhance biostatistical research capacity and help meet the high demand for oncology biostatistical support, the OICR BTI is piloting the Junior Biostatistician Award aimed at placing a recent biostatistician graduate at an Ontario host institution, guided by a principal applicant and biostatistics mentor.

With support from the OICR BTI Junior Biostatistician Award, applicant team members will be expected to identify a recently trained biostatistician with the required technical knowledge and skillset required to collaborate with existing host institution researchers to support enhanced high impact research. Through this new placement, the Junior Biostatistician will engage in interdisciplinary, collaborative cancer research.